PhillyCooke Consulting

21st Century FDA Ad-Promo Expertise

▼

Recap of FDLI #AdPromo2023

›
Disclosure: I sit on the Planning Committee for the FDLI Ad-Promo conference. This is an unpaid, volunteer position. The contents of this po...

COVID-19 & Ad-Promo

›
The COVID-19 pandemic has brought to the fore some issues of ad-promo for FDA-regulated products. I'm posting here to highlight some dev...

COVID-19 Outbreak Pausing Live Speaking Engagements

›
I live in Pennsylvania, just outside Philadelphia, in Montgomery County. Currently, Montco is the worst hit county in Pennsylvania for the C...

2020 CDER Guidance Agenda Released

›
UPDATE: The guidance mentioned below was released. Here's the link. The FDA has released the CDER Guidance Agenda . For ad-promo profe...

Temple RA/QA Advertising Course

›
It was just confirmed that I'll be teaching in Temple University's RA/QA MS program this spring. Specifically, I'll be teaching ...

DHC Privacy Post

›
The Digital Health Coalition asked for my views on the renewed emphasis on privacy for pharmaceutical marketers. I shared a few thoughts her...

Expanded Service Offerings

›
PhillyCooke Consulting has added new services from the humble start more than five years ago, when I used to joke that the company included ...
›
Home
View web version
Powered by Blogger.